Sweden's pharmaceutical industry, particularly in the production of pharmaceutical intermediates, operates under stringent purity standards and environmental regulations. The cold Nordic climate offers a natural advantage for heat rejection, but the internal processes of chemical synthesis often require precise, high-temperature stability that conventional fluids cannot provide.
The demand for Perfluoropolyether oil has surged as Swedish firms transition toward continuous flow chemistry. These facilities require fluids that remain stable across extreme temperature gradients without reacting with aggressive pharmaceutical reagents or degrading under high-pressure conditions.
Furthermore, the Swedish commitment to "Green Chemistry" drives the need for non-toxic, non-flammable heat transfer fluid options. Reducing the carbon footprint of HVAC and industrial cooling systems is now a primary operational goal for plants in Stockholm and Gothenburg.
